Stopping Migraines in Their Tracks

Medical Frontiers

28m 00s
Broadcast on September 26, 2022 Available until September 26, 2023

New preventive drugs for migraines were approved in Japan in 2021. The drugs contain antibodies that target a substance that plays a key role in migraines. In a clinical trial, around 70% of patients had a 50% drop in headache frequency. Separately, an item essential to patients called a headache diary has been developed into a smartphone app by a Japanese company. Their entries are shared with their doctors, making consultations smoother and more efficient.

Program Outline